ArticleMolecular cancer research : MCR2017

IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.

Silvia Maifrede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.